NDC product
Bivalirudin in 0.9% Sodium Chloride
NDC 0338-9572 · Baxter Healthcare Corporation
Key facts
| Product NDC | 0338-9572 |
|---|---|
| Proprietary name | Bivalirudin in 0.9% Sodium Chloride |
| Labeler | Baxter Healthcare Corporation |
| Marketing category | NDA |
| Application number | NDA208374 |
| Marketing start | Dec 21, 2017 |
| Marketing end | Sep 15, 2022 |
| Listing certified through | Sep 15, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: